These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 28716467)

  • 1. Clinically relevant potential drug-drug interactions among outpatients: A nationwide database study.
    Jazbar J; Locatelli I; Horvat N; Kos M
    Res Social Adm Pharm; 2018 Jun; 14(6):572-580. PubMed ID: 28716467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and predictors of potential drug-drug interactions in Regione Emilia-Romagna, Italy.
    Gagne JJ; Maio V; Rabinowitz C
    J Clin Pharm Ther; 2008 Apr; 33(2):141-51. PubMed ID: 18315779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identifying high risk medications causing potential drug-drug interactions in outpatients: A prescription database study based on an online surveillance system.
    Toivo TM; Mikkola JA; Laine K; Airaksinen M
    Res Social Adm Pharm; 2016; 12(4):559-68. PubMed ID: 26459026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polypharmacy, aging and potential drug-drug interactions in outpatients in Taiwan: a retrospective computerized screening study.
    Lin CF; Wang CY; Bai CH
    Drugs Aging; 2011 Mar; 28(3):219-25. PubMed ID: 21250763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinically important potential drug-drug interactions in outpatient settings.
    Aparasu R; Baer R; Aparasu A
    Res Social Adm Pharm; 2007 Dec; 3(4):426-37. PubMed ID: 18082877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-drug interactions in pediatric oncology patients.
    Balk TE; van der Sijs IH; van Gelder T; Janssen JJB; van der Sluis IM; van Leeuwen RWF; Engels FK
    Pediatr Blood Cancer; 2017 Jul; 64(7):. PubMed ID: 28205376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of drug-drug interaction in atrial fibrillation patients based on a large claims data.
    Momo K; Kobayashi H; Sugiura Y; Yasu T; Koinuma M; Kuroda SI
    PLoS One; 2019; 14(12):e0225297. PubMed ID: 31815956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between number of drugs and potential drug-drug interactions in the elderly: a study of over 600,000 elderly patients from the Swedish Prescribed Drug Register.
    Johnell K; Klarin I
    Drug Saf; 2007; 30(10):911-8. PubMed ID: 17867728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Countrywide prevalence of critical drug interactions in Hungarian outpatients: a retrospective analysis of pharmacy dispensing data.
    Somogyi-Végh A; Ludányi Z; Erdős Á; Botz L
    BMC Pharmacol Toxicol; 2019 May; 20(1):36. PubMed ID: 31151485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential drug-drug interactions in pediatric outpatient prescriptions for newborns and infants.
    Yeh ML; Chang YJ; Yeh SJ; Huang LJ; Yen YT; Wang PY; Li YC; Hsu CY
    Comput Methods Programs Biomed; 2014; 113(1):15-22. PubMed ID: 24209715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prevalence of major drug-drug interactions in older adults with cancer and the role of clinical decision support software.
    Nightingale G; Pizzi LT; Barlow A; Barlow B; Jacisin T; McGuire M; Swartz K; Chapman A
    J Geriatr Oncol; 2018 Sep; 9(5):526-533. PubMed ID: 29510896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potentially severe drug interactions in elderly outpatients: results of an observational study of an administrative prescription database.
    Nobili A; Pasina L; Tettamanti M; Lucca U; Riva E; Marzona I; Monesi L; Cucchiani R; Bortolotti A; Fortino I; Merlino L; Walter Locatelli G; Giuliani G
    J Clin Pharm Ther; 2009 Aug; 34(4):377-86. PubMed ID: 19583670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of potentially serious drug-drug interactions among South African elderly private health sector patients using the Mimica Matanović/Vlahović-Palčevski protocol.
    van Heerden JA; Burger JR; Gerber JJ; Vlahović-Palčevski V
    Int J Pharm Pract; 2018 Apr; 26(2):156-164. PubMed ID: 28665037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical relevance of drug-drug interactions in hospitalized dermatology patients.
    Ganeva M; Gancheva T; Troeva J; Kiriyak N; Hristakieva E
    Adv Clin Exp Med; 2013; 22(4):555-63. PubMed ID: 23986216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinically relevant drug-drug interactions among elderly people with dementia.
    Sönnerstam E; Sjölander M; Lövheim H; Gustafsson M
    Eur J Clin Pharmacol; 2018 Oct; 74(10):1351-1360. PubMed ID: 29967921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retrospective drug utilization review: incidence of clinically relevant potential drug-drug interactions in a large ambulatory population.
    Peng CC; Glassman PA; Marks IR; Fowler C; Castiglione B; Good CB
    J Manag Care Pharm; 2003; 9(6):513-22. PubMed ID: 14664659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticholinergic Burden in Children, Adults and Older Adults in Slovenia: A Nationwide Database Study.
    Cebron Lipovec N; Jazbar J; Kos M
    Sci Rep; 2020 Jun; 10(1):9337. PubMed ID: 32518392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of the French healthcare insurance database to estimate the prevalence of exposure to potential drug-drug interactions.
    Souty C; Launay T; Steichen O; Conte C; Turbelin C; Sarazin M; Vilcu AM; Rossignol L; Blanchon T; Lapeyre-Mestre M; Hanslik T
    Eur J Clin Pharmacol; 2020 Dec; 76(12):1675-1682. PubMed ID: 32632714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of two databases to detect potential drug-drug interactions between prescriptions of HIV/AIDS patients in critical care.
    Ramos GV; Guaraldo L; Japiassú AM; Bozza FA
    J Clin Pharm Ther; 2015 Feb; 40(1):63-7. PubMed ID: 25329640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of potential drug-drug interactions with a prescription claims database.
    Malone DC; Hutchins DS; Haupert H; Hansten P; Duncan B; Van Bergen RC; Solomon SL; Lipton RB
    Am J Health Syst Pharm; 2005 Oct; 62(19):1983-91. PubMed ID: 16174833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.